These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4675649)

  • 1. Supersensitivity of salivation in response to pilocarpine after withdrawal of chronically administered hyoscine in the mouse.
    Parkes MW; Parks JC
    Br J Pharmacol; 1972 Oct; 46(2):315-23. PubMed ID: 4675649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system supersensitivity to pilocarpine after withdrawal of chronically administered scopolamine.
    Friedman MJ; Jaffe JH; Sharpless SK
    J Pharmacol Exp Ther; 1969 May; 167(1):45-55. PubMed ID: 5814496
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of the effects of oral and i.m. atropine and hyoscine in volunteers.
    Mirakhur RK
    Br J Anaesth; 1978 Jun; 50(6):591-8. PubMed ID: 666935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical response of hyoscine plus morphine premedication in connection with cardiopulmonary bypass surgery.
    Kentala E; Kaila T; Arola M; Mattila M; Kanto J
    Eur J Anaesthesiol; 1991 Mar; 8(2):135-40. PubMed ID: 1874209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of anticholinergic drug effects in mice by antagonism against pilocarpine-induced salivation.
    Richter W
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):243-54. PubMed ID: 6013093
    [No Abstract]   [Full Text] [Related]  

  • 6. Pilocarpine-induced salivation and thirst in conscious rats.
    Sato N; Ono K; Honda E; Haga K; Yokota M; Inenaga K
    J Dent Res; 2006 Jan; 85(1):64-8. PubMed ID: 16373683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivation in mice as an index of adrenergic activity. II. The effects of atropines and ganglionic blocking agents on adrenergic salivation and temperature responses in mice.
    Koppanyi T; Maling HM
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):333-43. PubMed ID: 4403619
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine.
    Ziv I; Versano D; Ruach M; Izraeli S; Almog S; Alhalel A; Alkalay M; Menahem S; Tochner Z
    Br J Clin Pharmacol; 1992 May; 33(5):507-10. PubMed ID: 1524963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Damage of the medial preoptic area impairs peripheral pilocarpine-induced salivary secretion.
    Lopes de Almeida R; De Luca LA; de Almeida Colombari DS; Menani JV; Renzi A
    Brain Res; 2006 Apr; 1085(1):144-8. PubMed ID: 16580646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
    Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
    Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atropine, methylatropine, methylscopolamine and pilocarpine on salivary secretion and heart rate in man.
    Pohto P; Ahtee L
    Ann Med Exp Biol Fenn; 1966; 44(3):411-4. PubMed ID: 5959658
    [No Abstract]   [Full Text] [Related]  

  • 12. Central muscarinic receptors signal pilocarpine-induced salivation.
    Takakura AC; Moreira TS; Laitano SC; De Luca Júnior LA; Renzi A; Menani JV
    J Dent Res; 2003 Dec; 82(12):993-7. PubMed ID: 14630901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxonidine and rilmenidine injected into the medial septal area reduces the salivation induced by pilocarpine.
    Saad WA; de Arruda Camargo LA; Simões S; Saad WA; Guarda RS; Guarda IF
    Auton Neurosci; 2004 May; 112(1-2):31-6. PubMed ID: 15233928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of long-term pilocarpine due to increased muscarinic acetylcholine receptor 3 in salivary glands.
    Minagi HO; Ikai K; Araie T; Sakai M; Sakai T
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1098-1102. PubMed ID: 29953856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic and pharmacodynamic study of intravenous pilocarpine in humans.
    Tanzer JM; Kramer PA; Schulman P; Willard AK
    J Dent Res; 1995 Dec; 74(12):1845-9. PubMed ID: 8600180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs.
    Gianutsos G
    Psychopharmacology (Berl); 1979 Nov; 66(2):121-5. PubMed ID: 119254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The time course of action of (-)-hyoscine after intramuscular injection.
    Brand JJ
    Br J Pharmacol; 1969 Jan; 35(1):202-8. PubMed ID: 5762041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of N-methyl-hyoscine methyl sulfate (DD-234 or 1290 CERM) upon the gastrointestinal motility and salivation].
    Hukuhara T; Fukuda H; Nakayama S; Neya T; Tsuchiya K
    Nihon Heikatsukin Gakkai Zasshi; 1970 Dec; 6(4):263-9. PubMed ID: 4395992
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of transdermal scopolamine on salivation.
    Gordon C; Ben-Aryeh H; Attias J; Szargel R; Gutman D
    J Clin Pharmacol; 1985 Sep; 25(6):407-12. PubMed ID: 4056076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine-induced and pilocarpine-induced hypothermia in mice: drug interactions and changes in drug sensitivity after caudate nucleus lesions.
    Glick SD; Marsanico RG
    Br J Pharmacol; 1974 Jul; 51(3):353-7. PubMed ID: 4451749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.